Abstract
Background and aims
Factors related to mortality after upper gastrointestinal (GI) bleeding may differ in importance in high- and low-risk populations. This retrospective study was undertaken to define risk factors of mortality in patients needing endoscopy for upper gastrointestinal bleeding at a tertiary care centre.
Patients/methods
Three hundred and sixty-two patients with upper gastrointestinal bleeding were identified from endoscopy charts. Patients’ characteristics, bleeding parameters, clinical presentation, pre-existing medication and laboratory data were retrieved from hospital charts and patients who survived and those who died in hospital were compared.
Results/findings
The mean Rockall score was 6.6±1.3 with 92.5% of patients belonging to a Rockall high-risk group. In hospital, mortality was 26.5%, with 6.4% of patients dying as a direct consequence of bleeding. Variceal bleeding was associated with a high risk of recurrent bleeding and death. Renal disease, liver disease, coagulopathy and immunosuppression were more frequently found in non-survivors than in survivors. Accordingly, serological tests of renal or liver function and coagulation were more disturbed in non-survivors. On average, heart rate was higher, and blood pressure and haemoglobin levels lower in non-survivors. Heparin, glucocorticoids, and anti-ulcer drugs were more frequently used in patients dying in hospital. By logistic regression analysis, in-patient status at the time of bleeding, renal disease and coagulopathy, as well as glucocorticoid use, were risk factors for hospital mortality.
Interpretation/conclusion
In tertiary care, a high mortality rate is observed in upper GI bleeding. Teams involved in treating such patients should be aware of the setting in which treatment is performed and its related risk factors.
Similar content being viewed by others
References
Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE (1995) Analysis of 3,294 cases of upper gastrointestinal bleeding in military facilities. Am J Gastroenterol 90:568–573
Allan R, Dykes P (1976) A study of the factors influencing mortality rates from gastrointestinal haemorrhage. Q J Med 180:533–550
Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J (1981) The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 27:73–79
Hay JA, Lyubahevsky E, Elashoff J, Maldonado L, Weingarten SR, Ellrodt AG (1996) Upper gastrointestinal hemorrhage clinical guideline—determining the optimal hospital length of stay. Am J Med 100:313–322
Rockall TA, Logan RFA, Devlin HB, Northfield TC (1997) Influencing the practice and outcome in acute upper gastrointestinal haemorrhage. Gut 41:606–611
Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J (1997) Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. Br Med J 315:510–514
Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J (1981) The national ASGE survey on upper gastrointestinal tract hemorrhage. I. Study design and baseline data. Gastrointest Endosc 27:73–79
Rockall TA, Logan RFA, Devlin HB, Northfield TC (1995) Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Br Med J 311:222–226
Sandel MH, Kolkmann JJ, Kuipers EJ, Cuesta MA, Meuwissen SG (2000) Nonvariceal upper gastrointestinal bleeding: differences in outcome for patients admitted to internal medicine and gastroenterological services. Am J Gastroenterol 95:2357–2362
Terdiman JP (1998) Update on upper gastrointestinal bleeding. Basing treatment decision on patients’ risk level. Postgrad Med 6:103–106
Depolo A, Dobrila-Dintinjana R, Uravi M, Grbas H, Rubini M (2001) Die obere gastrointestinale Blutung. Ein Überblick über unsere 10-Jahres-Ergebnisse. [Upper gastrointestinal bleeding. Review of our ten years results.] Zentralbl Chir 126:772–776
Cook D, Guyatt GH, Salena BJ, Laine L (1992) Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 102:139–148
Cooper GS, Chak A, Way LE, Hammar PJ, Harper DL, Rosenthal GE (1999) Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointest Endosc 49:145–152
Chak A, Cooper GS, Lloyd LE, Kolz CS, Barnhart BA, Wong RC (2001) Effectiveness of endoscopy in patients admitted to the intensive care unit with upper gastrointestinal hemorrhage. Gastrointest Endosc 53:5–13
Lee JG, Turnipseed S, Romano PS, Vigil H, Azari R, Melnikoff N, Hsu R, Kirk D, Sokolove P, Leung JW (1999) Endoscopy-based triage significantly reduce hospitalisation rates and costs of treating upper GI bleeding. Gastrointest Endosc 50:755–761
Kolkman JJ, Meuwissen SG (1996) A review on treatment of bleeding peptic ulcer: a collaborative task of gastroenterologist and surgeon. Scand J Gastroenterol 218 [Suppl]:16–25
Lin HJ, Perng CL, Lee FY, Lee CH, Lee SD (1994) Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut 35:1389–1393
Terdiman JP, Ostroff JW (1997) Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy. Am J Gastroenterol 92:1805–1811
Palmer KR (2000) Ulcers and non-variceal bleeding, state-of-the-art review. Endoscopy 32:118–123
Clason AE, Macleod DAD, Elton RA (1986) Clinical factors in the prediction of further hemorrhage or mortality in acute upper gastrointestinal hemorrhage. Br J Surg 73:85–87
Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai ECS, Mok SPT, Cheung WL, Lau PWK, Tuen HH, Lam SK, Hui WM, Ng MMT, Lam DKH, Dip T, Tang APK, Wong J (1990) Bleeding peptic ulcer: a prospective evaluation of risk factors for bleeding and mortality. World J Surg 14:262–270
Morgan AG, McAdam WAF, Walmsley GL, Jessop A, Horrocks JC, De Dombal FT (1977) Clinical findings, early endoscopy, and multivariate analysis in patients bleeding from the upper gastrointestinal tract. Br Med J 2:237–240
Schiller KFR, Truelove SC, Williams DG (1970) Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J 2:7–14
Rockall TA, Logan RFA, Devlin HB, Northfield TC (1996) Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38:316–321
Lewis JD, Shin EJ, Metz DC (2000) Characterization of gastrointestinal bleeding in severely ill hospitalised patients. Crit Care Med 28:46–50
Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJR, Roy P, Lacroix J, Griffith L, Willan A (1994) Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330:377–381
Schuster DP, Rowley H, Feinstein S, McGue MK, Zuckerman GR (1984) Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 76:623–630
Ellison RT III, Perez-Perez G, Welsh CH, Blaser MJ, Riester KA, Cross AS, Donta ST, Peduzzi P (1996) Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of Helicobacter pylori. Crit Care Med 24:1974–1981
Zimmerman J, Meroz Y, Siguencia J, Tsvang E, Arnon R (1994) Upper gastrointestinal hemorrhage. Comparison of the causes and prognosis in primary and secondary bleeders. Scand J Gastroenterol 29:795–798
Johnston SJ, Jones PF, Kyle J, Needham CD (1973) Epidemiology and course of gastrointestinal haemorrhage in north-east Scotland. Br Med J 3:655–660
Longstreth GF, Feitelberg SP (1995) Outpatient care of selected patients with acute non-variceal upper gastrointestinal haemorrhage. Lancet 345:108–111
Ell C, Hagenmüller F, Schmitt W, Riemann JF, Hahn EG, Hohenberger W (1995) Multizentrische prospektive Untersuchung zum aktuellen Stand der Therapie der Ulkusblutung in Deutschland. [Multi-centre prospective study of the current state of treatment in Germany of bleeding peptic ulcer.] Dtsch Med Wochenschr 120:3–9
D’Amico G, Pagliaro L, Bosch J (1999) Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19:475–505
Klebl F, Langgartner J, Bregenzer N, Tamme W, Schöfer L, Schölmerich J, Messmann H (2002) Charakterisierung der oberen gastrointestinalen Blutung bei Intensivpatienten. [Characteristics of critically ill patients with upper gastrointestinal bleeding.] Intensivmed 39:233–239
Peura DA, Lanza FL, Gostout CJ, Fouch PG (1997) The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 92:924–928
Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M (1994) Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 39:706–712
Blatchford O, Murray WR, Blatchford M (2000) A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 356:1318–1321
Inayet N, Amoateng-Adjepong Y, Upadya A, Manthous CA (2000) Risks for developing critical illness with GI hemorrhage. Chest 118:473–478
Afessa B, Kubilis PS (2000) Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 95:484–489
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klebl, F., Bregenzer, N., Schöfer, L. et al. Risk factors for mortality in severe upper gastrointestinal bleeding. Int J Colorectal Dis 20, 49–56 (2005). https://doi.org/10.1007/s00384-004-0624-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-004-0624-2